Followers | 129 |
Posts | 2150 |
Boards Moderated | 1 |
Alias Born | 12/27/2007 |
Monday, February 11, 2019 11:59:31 AM
Recent CLSD News
- Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 11:05:00 AM
- Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer • GlobeNewswire Inc. • 03/18/2024 11:05:00 AM
- Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024 • GlobeNewswire Inc. • 02/29/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:05:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/08/2024 09:52:44 PM
- Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:01:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 11:25:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/19/2024 08:04:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:10:07 PM
- Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD • GlobeNewswire Inc. • 12/14/2023 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:10:13 PM
- Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 12:05:00 PM
- Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting • GlobeNewswire Inc. • 11/07/2023 09:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 04:01:10 PM
- BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector® • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting • GlobeNewswire Inc. • 11/02/2023 11:05:00 AM
- Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD • GlobeNewswire Inc. • 11/01/2023 11:05:00 AM
- Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023 • GlobeNewswire Inc. • 10/31/2023 11:05:00 AM
- Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting • GlobeNewswire Inc. • 10/16/2023 11:05:00 AM
- Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific for Suprachoroidal Treatment of Uveitic Macular Edema as Partner Arctic Vision Completes Enrollment in Phase 3 Clinical Trial in China • GlobeNewswire Inc. • 10/04/2023 01:00:00 PM
- Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit • GlobeNewswire Inc. • 10/03/2023 08:35:00 PM
UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM
Kona Gold Beverages & Apple Rush Co. Execute Joint Venture & Manufacturing Agreement • APRU • Apr 11, 2024 9:40 AM
VAYK Confirmed Its Eligibility for $1.8 Million Investment through Federal EB5 Program • VAYK • Apr 11, 2024 9:00 AM
ILUS Moves Forward With Its Two Subsidiary Uplists and Equity Dividend • ILUS • Apr 10, 2024 9:36 AM
Quartz Intersects 102m of 2.22 g/t Au and 104 g/t Ag Announces New Discovery at Prodigy on its Maestro Project, British Columbia • QZM • Apr 10, 2024 8:00 AM
Swifty Global Announces Record Annual Results Ahead of National Exchange Reverse Merger • DRCR • Apr 9, 2024 1:55 PM